EP
WST icon

Eudaimonia Partners’s West Pharmaceutical WST Stock Holding History

Eudaimonia Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,617
Closed -$664K – 447
2022
Q1 		$664K Buy
+1,617
New +$633K 0.11% 206
2021
Q3 		$711K Buy
1,674
+28
+2% +$11.8K 0.13% 189
2021
Q2 		$591K Buy
1,646
+1,536
+1,396% +$507K 0.11% 211
2021
Q1 		$31K Buy
+110
New +$31.5K 0.01% 800

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Eudaimonia Partners's WST Position: Q2 2022 in Review

Eudaimonia Partners sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 1,617 shares — an estimated $664K sold.

Eudaimonia Partners first reported a position in WST in Q1 2021 and held it in 4 quarters. The position peaked at $711K in Q3 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Eudaimonia Partners reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Eudaimonia Partners sold 1,617 West Pharmaceutical shares in Q2 2022, an estimated $664K.
  • Eudaimonia Partners first reported a position in West Pharmaceutical in Q1 2021 and held it in 4 quarters.
  • Eudaimonia Partners's West Pharmaceutical position peaked at $711K in Q3 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Eudaimonia Partners's 13F filing for Q2 2022, filed 9 Aug 2022.